SynthesisFrontiers in oncology2024

PD-L1 expression as a potential predictor of immune checkpoint inhibitor efficacy and survival in patients with recurrent or metastatic nasopharyngeal cancer: a systematic review and meta-analysis of prospective trials.

Ruyu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.